UNSPSC 51182060: Nandrolone phenpropionate

This classification denotes a therapeutic androgen with the molecular formula C27H34O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KF7Z9K2T3W, chemically known as 19-nortestosterone, hydrocinnamate but more generally known as nandrolone phenpropionate, which bears US NIH Compound Identifier 4435. European Medicines Agency schedules Nandrolone phenpropionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03385MIG.

UNSPSC 51182060 Nandrolone phenpropionate is a Commodity code covering a pharmaceutical steroid compound used in state and local health care and corrections settings. The work being solicited under this code consists of procurement of nandrolone phenpropionate itself — a controlled anabolic steroid — for use in medical treatment programs, typically in correctional facilities, public health departments, or state-operated medical clinics where the drug is administered under clinical supervision for therapeutic purposes such as treatment of muscle-wasting conditions or recovery from severe injury or surgery. State and local issuing bodies purchasing this commodity include state departments of health and human services, state corrections departments, county health authorities, and municipal health clinics. The drug is a prescription pharmaceutical subject to DEA scheduling and supply-chain controls, and procurement typically follows standard pharmaceutical acquisition processes through state contracts or cooperative purchasing vehicles.

The source provides no recent state and local solicitations or contract opportunities under this code, making current market activity assessment unavailable. Without visibility into recent RFP, RFQ, IFB, or ITB notices posted by state or local entities, geographic concentration and representative recent opportunities cannot be determined from this source.